Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

Fig. 4

QoL scales (EORTC QLQ C30 and EORTC QLQ BR 23) by therapy arm with statistical significant changes over the time. Legende.4a Global health status (C30) p=0.003; 4b. Emotional Functioning (C30) p =0.013; 4c. Cognitive Functioning (C30) p=0.006; 4d. Dyspnoea (C 30) p=0.026; 4e. Financial problems (C30) p=0.031; 4f.Future perspective (BR 23) p=0.009; 4g. Body image (BR 23) p=0.018; 4h. Breast symptoms (BR23). p=0.006; 2i. Systemic therapy (BR23) p<0.0001; 4j. Hair loss (BR 23) p<0.0001; 4k. Box Plot Legende: Mean value therapy arm A -Surgical therapy; + mean value thearpy arm B- no surgical therapy

Back to article page